PRETERM LABOR
THE TECHNOLOGY
e-Bio's proprietary technology is based on the concept of electric inhibition, meaning that by using an electric signal we are able to affect uterine contractions. By applying this stimulation towards the women's uterus, we can diminish or stop contractions on preterm pregnancies.
THE DEVICE
e-Bio is currently working with different prototypes aiming to find the optimal solution for the final product. e-Bio have FDA's IDE for use of the device in clinical trials.
STUDIES AND RESULTS
e-Bio's co-founders have extensively published data regarding electric inhibition of uterine contractions. From early animal studies to more recent human trials currently being conducted.
The results are very encouraging, showing e-Bio's device was able to diminish or stop uterine contractions on preterm labor patients.
The first phase trial, currently on the way, is supported by a grant from March of Dimes, one of the largest organizations on the fight for the health of all moms and babies.
THE TEAM
Where the Passion Begins
DENIS SCHAPIRA WAJMAN
CEO
FREDERICK NAFTOLIN
Chief Medical Officer
JEFFREY KARSDON
Chief Scientific Officer